Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4288 | 1736 | 29.6 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1449 | 7299 | INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PSEUDOMYXOMA PERITONEI | Author keyword | 348 | 76% | 14% | 247 |
2 | HIPEC | Author keyword | 307 | 82% | 10% | 177 |
3 | PERITONEAL CARCINOMATOSIS | Author keyword | 282 | 55% | 20% | 355 |
4 | CYTOREDUCTIVE SURGERY | Author keyword | 218 | 55% | 16% | 277 |
5 | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY | Author keyword | 187 | 75% | 8% | 134 |
6 | INTRAPERITONEAL CHEMOTHERAPY | Author keyword | 146 | 45% | 14% | 242 |
7 | PERITONECTOMY | Author keyword | 131 | 72% | 6% | 102 |
8 | DISSEMINATED PERITONEAL ADENOMUCINOSIS | Author keyword | 69 | 96% | 1% | 22 |
9 | PERITONEAL SURFACE MALIGNANCY | Author keyword | 58 | 92% | 1% | 23 |
10 | HEATED INTRAPERITONEAL CHEMOTHERAPY | Author keyword | 44 | 100% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEMOHYPERTHERMIA | 376 | 88% | 10% | 179 |
2 | CARCINOMATOSIS | 295 | 58% | 20% | 343 |
3 | PSEUDOMYXOMA PERITONEI | 233 | 55% | 17% | 293 |
4 | HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY | 232 | 67% | 12% | 209 |
5 | CYTOREDUCTIVE SURGERY | 230 | 36% | 29% | 508 |
6 | APPENDICEAL ORIGIN | 151 | 88% | 4% | 72 |
7 | HYPERTHERMIC CHEMOTHERAPY | 133 | 92% | 3% | 54 |
8 | SURFACE MALIGNANCY | 133 | 92% | 3% | 54 |
9 | PERITONEAL CARCINOMATOSIS | 131 | 40% | 15% | 254 |
10 | ADENOMUCINOSIS | 115 | 89% | 3% | 51 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases | 2014 | 17 | 53 | 85% |
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? | 2006 | 230 | 29 | 93% |
Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality | 2009 | 104 | 41 | 76% |
Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States | 2014 | 7 | 5 | 100% |
A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin | 2009 | 72 | 57 | 93% |
A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer | 2015 | 1 | 44 | 55% |
A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei | 2007 | 96 | 41 | 98% |
Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma | 2006 | 132 | 49 | 76% |
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | 2009 | 58 | 46 | 76% |
Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials | 2014 | 11 | 36 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PERITONEAL SUR E MALIGNANCY PROGRAM | 33 | 77% | 1.3% | 23 |
2 | PROGRAM PERITONEAL SUR E MALIGNANCY | 25 | 77% | 1.0% | 17 |
3 | PERITONEAL MALIGNANCY | 20 | 100% | 0.5% | 9 |
4 | PSEUDOMYXOMA PERITONEI | 15 | 77% | 0.6% | 10 |
5 | WASHINGTON CANC | 13 | 25% | 2.7% | 47 |
6 | SURG ONCOL SERV | 11 | 33% | 1.6% | 27 |
7 | HEPATOBILIARY SURG ONCOL UNIT | 9 | 40% | 1.0% | 18 |
8 | PERITONEAL SUR E MALIGNANCY UNIT | 9 | 83% | 0.3% | 5 |
9 | PERITONEAL TUMOUR SERV | 9 | 83% | 0.3% | 5 |
10 | SERV CHIRURG GEN THORAC ENDOCRINIENNE | 9 | 83% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228653 | INTRAPERITONEAL CHEMOTHERAPY//INTRAPERITONEAL//INTRAPERITONEAL THERAPY |
2 | 0.0000205468 | APPENDIX//GOBLET CELL CARCINOID//MUCOCELE |
3 | 0.0000199527 | PERITONEAL LAVAGE CYTOLOGY//J AN FOOD EDUC HLTH//PERITONEAL CYTOLOGY |
4 | 0.0000062447 | WHOLE BODY HYPERTHERMIA//THERMOCHEMOTHERAPY//INTRACELLULAR PLATINUM UPTAKE |
5 | 0.0000051310 | KRUKENBERG TUMOR//OVARIAN METASTASIS//OVARIAN METASTASES |
6 | 0.0000046769 | INTERVAL DEBULKING SURGERY//SECONDARY CYTOREDUCTIVE SURGERY//ADVANCED OVARIAN CANCER |
7 | 0.0000044974 | DESMOPLASTIC SMALL ROUND CELL TUMOR//DSRCT//EWS WT1 |
8 | 0.0000043287 | MESOTHELIOMA//MALIGNANT PLEURAL MESOTHELIOMA//EXTRAPLEURAL PNEUMONECTOMY |
9 | 0.0000040508 | ACTIVATED CARBON PARTICLES//LYMPH NODE TARGETING//LYMPHATIC TARGETING |
10 | 0.0000037444 | MALIGNANT BOWEL OBSTRUCTION//BOWEL OBSTRUCTION//VENTING GASTROSTOMY |